Navigation Links
Georgetown Lombardi Comprehensive Cancer Center Taps Ariadne for G-DOC Pathway Data and Tools

ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire/ -- Ariadne, a leader in bioinformatics software and knowledge integration, announces today that Georgetown University signed a site license for the use of Pathway Studio® software.  In continuing its goal of adopting and applying innovative technologies, Georgetown Lombardi Comprehensive Cancer Center will employ Pathway Studio to aid researchers in their efforts to unravel cancer disease biology, disease progression, and translational medicine.  These research findings will be shared using Pathway Studio through the Georgetown Database of Cancer (G-DOC) initiative.

"Translational medicine has become increasingly important as an investigative tool to help identify biomarkers and surrogate markers involved with disease or therapeutic response.  Finding tools that can help integrate published findings with our microRNA experimental data is exciting as this advancement will enhance our ability to create disease models and hypotheses more rapidly and with greater accuracy," states Dr. Subha Madhavan, Director of Clinical Research Informatics at Georgetown Lombardi.

"Ariadne's expertise in developing biological knowledgebases for disease modeling fits nicely into Georgetown Lombardi's vision and goals.  We look to help them achieve greater understanding of cancer and to apply these discoveries to have the greatest impact in translational medicine," states Ilya Mazo, president of Ariadne.

Pathway Studio's workflow approach allows researchers to mine, integrate, analyze and visualize results individually or as an integrated workflow.  Each step can be saved, then updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.  

For more information about Pathway Studio and Ariadne, visit the Ariadne website at, or call 240-453-6296, or email us at

About Ariadne Ariadne (, a leader in research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine. We provide a portfolio of solutions for life science, drug discovery and development applications including custom data products, knowledge extraction and visualization software, knowledge reports, and informatics staffing.

Pathway Studio, built and powered by MedScan® technology, is integrated data mining and visualization software that allows organizations and researchers to rapidly extract relevant facts and relationships from large document collections (text-mining), build focused knowledgebases (databases), while supporting the integration of OMICS experiments. The extracted knowledge is used in an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modelling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.

Pathway Studio is available in desktop and enterprise versions along with therapeutic-focused knowledgebases and cartridges. For more information, visit us at

About Georgetown Lombardi Comprehensive Cancer CenterGeorgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to Contact:David DennyDirector of Marketing, AriadneEmail: Tel: 240-453-6296

SOURCE Ariadne
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Amphotericin B - Comprehensive patent search
2. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
3. Terrorist de-radicalization shows promise, comprehensive study finds
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral Metabolism Practice Patterns Around the Globe
6. Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos
7. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
8. The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
11. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Sciences today announced the three Winners and six Finalists of the 2017 Blavatnik ... annually by the Blavatnik Family Foundation and administered by the New York Academy ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... ( ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... Md. (PRWEB) , ... October 11, 2017 , ... ... digital pathology, announced today it will be hosting a Webinar titled, “Pathology is ... Advanced Pathology Associates , on digital pathology adoption best practices and how Proscia ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:7/20/2017)... July 20, 2017 Delta (NYSE: DAL ) customers ... Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft ... Delta,s biometric boarding pass ... is now integrated into the boarding process to allow eligible Delta ...
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/23/2017)... GENOA, Italy , May 23, 2017  Hunova, the first robotic ... and trunk, has been officially launched in Genoa, Italy ... Europe and the USA . The ... launched on the market by the IIT spin-off Movendo Technology thanks to ... view the Multimedia News Release, please click: ...
Breaking Biology News(10 mins):